Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:COH
ASX:COHMedical Equipment

How Cochlear’s FY26 Profit Downgrade At Cochlear (ASX:COH) Has Changed Its Investment Story

Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets. This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions. We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...
BIT:RACE
BIT:RACEAuto

Is Ferrari (BIT:RACE) Pricing Still Justified After A 26% One-Year Share Price Slide

If you are wondering whether Ferrari's current share price reflects its true worth, you are not alone. This article focuses on what the numbers suggest about value rather than the brand's prestige. Ferrari shares last closed at €293.35, after a 4.1% decline over the past week, a 1.5% gain over the last month, and returns of 7.3% decline year to date and 26.1% decline over the past year. This may catch the eye of investors reassessing risk and opportunity. Recent coverage has highlighted...
OM:ERIC B
OM:ERIC BCommunications

Is It Time To Reassess Ericsson (OM:ERIC B) After Its Strong Three Year Share Price Run

Wondering if Telefonaktiebolaget LM Ericsson is fairly priced or if the market is overlooking something? This article walks through the key numbers so you can judge the current share price with more confidence. The stock last closed at SEK108.35 and has returns of 2.6% over 7 days, 1.9% over 30 days, 22.7% year to date and 37.6% over 1 year, with a 121.0% return over 3 years and 12.8% over 5 years. Recent share price performance sits alongside an ongoing flow of news around Ericsson's role...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Is It Too Late To Consider Warner Bros. Discovery (WBD) After 221% One Year Surge?

If you are wondering whether Warner Bros. Discovery at around US$27.05 is still offering value after a strong run, this breakdown will help you understand what the current price actually reflects. The stock has returned 0.6% over the last week and 220.9% over the past year, even though the year to date return sits at a 5.1% decline and the five year return is a 25.4% decline. Recent headlines have focused on Warner Bros. Discovery's positioning across streaming, film, and TV content, as...
NYSE:LMND
NYSE:LMNDInsurance

Lemonade (LMND) Losses Narrow In Q4 2025 Challenging Bearish Profitability Narratives

Lemonade (LMND) opened Q1 2026 earnings season with Q4 2025 revenue of US$228.4 million and a basic EPS loss of US$0.29, alongside net income excluding extra items of a US$21.7 million loss. Over the past year, the company reported quarterly revenue increasing from US$151.2 million in Q1 2025 to US$228.4 million in Q4 2025, while quarterly basic EPS losses narrowed from US$0.86 in Q1 2025 to US$0.29 in Q4 2025. For investors, the latest results focus attention on how quickly Lemonade can...
ENXTPA:MC
ENXTPA:MCLuxury

Why LVMH (ENXTPA:MC) Is Down 5.0% After Dividend Approval And Revenue Decline Amid Middle East Tensions

In April 2026, LVMH Moët Hennessy - Louis Vuitton’s shareholders approved a €13.00 per-share dividend for 2025, while the group also reported a 6% revenue decline linked partly to Middle East disruption and temporary store closures. At the same time, LVMH and its Stella McCartney brand face a U.S. lawsuit alleging anti-competitive pricing, pay disparities, and whistleblower retaliation, adding legal and governance questions to existing geopolitical and demand pressures on the luxury...
NYSE:JOE
NYSE:JOEReal Estate

St. Joe (JOE) Q1 EPS Compression Tests Bullish Premium Multiple Narrative

St. Joe (JOE) opened 2026 with Q1 revenue of US$99 million and basic EPS of US$0.24, compared with Q1 2025 revenue of US$94 million and EPS of US$0.30. Trailing twelve month EPS stood at US$1.94 on revenue of US$518 million. Over that same twelve month stretch, net income reached US$112 million, giving investors a fuller view of how quarterly earnings feed into the broader profit picture. With a net margin of 21.6% over the last year, the latest numbers keep the spotlight firmly on how...
ASX:NIC
ASX:NICMetals and Mining

Nickel Industries (ASX:NIC) Is Up 7.0% After Record EBITDA And Excelsior Progress Is The Bull Case Changed?

In late April 2026, Nickel Industries Limited reported its March quarter results, delivering record adjusted EBITDA of US$135.6 million, supported by a higher Indonesian production quota, accelerated ore sales, and progress on the Excelsior Nickel Cobalt project. Alongside this financial performance, the company highlighted a lost time injury frequency rate of 0.00, expanded conservation efforts over about 197 hectares of primary forest at Hengjaya, and a stronger liquidity position through...
NYSE:MTH
NYSE:MTHConsumer Durables

Is Meritage Homes (MTH) Pricing Look Interesting After Recent Share Price Swings?

If you are wondering whether Meritage Homes at around US$67.34 is a bargain or just fairly priced, this breakdown will help you frame what the current share price might actually be offering you. The stock has recently been choppy, with a 3.7% decline over the last 7 days, an 8.9% gain over the past 30 days, and returns of 1.7% year to date and 3.2% over the last year. Recent coverage has focused on how Meritage Homes fits into the broader US homebuilding sector, with attention on its ability...
NYSE:OC
NYSE:OCBuilding

Is Owens Corning (OC) Fairly Priced After Recent Share Price Rebound?

Wondering if Owens Corning is priced fairly today or offering value at a discount? This breakdown focuses squarely on what you are getting for the price you pay. The stock last closed at US$123.34, with returns of 14.0% over 30 days, 8.1% year to date, and a 13.2% decline over the past year. This puts recent gains and longer term performance in different lights. Recent coverage has focused on how investors are reassessing building and construction related names in light of changing...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

FERC’s PJM Ruling and Affordability Push Could Be A Game Changer For Exelon (EXC)

In late April 2026, Exelon’s board declared a regular quarterly dividend of $0.42 per share, payable on June 15, 2026, to shareholders of record as of June 4, and the company voiced support for a Federal Energy Regulatory Commission order extending the PJM capacity price collar to help lower customer costs. At its 2026 annual meeting, Exelon highlighted a four-year $41.30 billion capital plan and earnings guidance through 2029 while advancing “The Exelon Promise,” which includes cost...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf (DBD) EPS Turnaround Reinforces Bullish Narratives Ahead Of Q1 2026 Results

Diebold Nixdorf (DBD) has followed up its return to profitability by closing out 2025 with Q4 revenue of US$1,104.2 million and basic EPS of US$1.39, setting the stage for its freshly reported Q1 2026 results. Over the past year, the company has seen quarterly revenue move from US$988.9 million in Q4 2024 to US$841.1 million in Q1 2025, US$915.2 million in Q2 2025, US$945.2 million in Q3 2025, and US$1,104.2 million in Q4 2025. Over the same period, basic EPS shifted from US$0.15 to a loss of...
NasdaqGS:TXRH
NasdaqGS:TXRHHospitality

Is It Time To Reconsider Texas Roadhouse (TXRH) After Recent Restaurant Sector Headlines

If you are wondering whether Texas Roadhouse at around US$160.99 still offers value, the next sections will walk through what the current share price might be implying about the business. Over the last week the stock return is 0.3%, the 30 day return is a 2.5% decline and year to date the return is a 6.1% decline, while the 3 year and 5 year returns sit at 51.0% and 70.5% respectively. Recent headlines have kept Texas Roadhouse in focus, with ongoing attention on the broader restaurant...
TSE:6857
TSE:6857Semiconductor

Is Advantest (TSE:6857) Quietly Recasting Its AI Test Ambitions With New Tools And Funding Choices?

Advantest Corporation has recently reported full-year 2026 results showing higher sales and net income year-on-year, while its board held meetings to approve the disposal of treasury stock as restricted stock and the company continued to raise funding through zero-coupon convertible bonds. Alongside earnings, Advantest introduced its Pin Scale 5000B tester for AI and high-performance computing chips and deepened collaboration with Applied Materials through an Innovation Center on Applied’s...
TSE:6902
TSE:6902Auto Components

Is It Time To Reconsider DENSO (TSE:6902) After Recent Share Price Weakness?

For investors considering whether DENSO is attractively priced or whether the recent share price leaves limited room for upside, this article focuses on what the current valuation suggests about the stock. DENSO shares last closed at ¥1,895.5, with returns of 1.5% over 7 days, a 3.0% decline over 30 days, and a 13.1% decline year to date, while the 1 year return stands at 2.7% and the 5 year return at 21.8%. Recent coverage has focused on DENSO's role in the auto components space and how...
SGX:ME8U
SGX:ME8UIndustrial REITs

A Look At Mapletree Industrial Trust’s Valuation After Quarterly Loss And Weaker Full Year Sales

Mapletree Industrial Trust (SGX:ME8U) has drawn attention after reporting fourth quarter sales of S$163.76 million and a net loss of S$62.38 million, along with lower full year sales and earnings. See our latest analysis for Mapletree Industrial Trust. At a share price of S$1.97, Mapletree Industrial Trust has seen a 7 day share price return of 4.37% decline and a 90 day share price return of 6.64% decline. The 1 year total shareholder return of 3.92% suggests that longer term holders have...
NYSE:USFD
NYSE:USFDConsumer Retailing

Is It Too Late To Consider US Foods Holding (USFD) After Its Strong Five Year Run?

For readers wondering whether US Foods Holding is still reasonably priced after its recent run, or if the easy money has already been made, this article walks through what the current share price might be implying about value. At a last close of US$93.49, the stock has delivered returns of 0.7% over 7 days, 1.4% over 30 days, 25.3% year to date, 40.9% over 1 year and 133.0% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Is It Too Late To Consider Millicom International Cellular (TIGO) After Its 1-Year Surge?

Investors may be wondering whether Millicom International Cellular at about US$84.88 is still offering value after a strong run, or if most of the easy gains are already behind it. The stock has recent returns of 0.8% over 7 days, 13.3% over 30 days, 50.1% year to date and 177.5% over 1 year, with a very large 3-year gain and a more than 2x 5-year gain that can all influence how you think about risk and reward today. Recent coverage around Millicom International Cellular has focused on its...
NYSE:VZ
NYSE:VZTelecom

What Verizon Communications (VZ)'s First-Quarter Turnaround in Postpaid Phone Growth Means For Shareholders

In the first quarter of 2026, Verizon Communications reported revenue of US$34,440 million and net income of US$5,045 million, with basic and diluted EPS from continuing operations of US$1.20, all modestly higher than a year earlier. The company coupled this earnings beat and guidance raise with its first positive first-quarter postpaid phone net additions since 2013 and highlighted AI-focused partnerships and operational improvements under new CEO Dan Schulman. We’ll now examine how...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After Its 192% One-Year Surge?

If you are wondering whether Centessa Pharmaceuticals at around US$39.42 is still offering value after its surge, you are asking the right question for this stock. The share price has delivered a 66.4% return year to date and 192.0% over the last year, with the 3 year return described as very large, even though the last 30 days have seen a small 0.8% decline and the last week has been flat at 0.0%. Recent coverage has focused on Centessa Pharmaceuticals as a higher growth biotech name, and...
ASX:RMS
ASX:RMSMetals and Mining

Ramelius Resources (ASX:RMS) Is Down 8.6% After Record Quarterly Profitability Amid Rising Diesel Costs – Has The Bull Case Changed?

On 29 April 2026, Ramelius Resources reported its most profitable quarter to date, delivering a very large all-in sustaining cost margin despite revising cost guidance higher due partly to accounting changes and stronger gold prices. At the same time, the company accelerated its share buyback and advanced high‑grade discoveries at Dalgaranga, underlining management’s conviction in the business while industry‑wide diesel cost pressures continued to reshape its operating cost base. We’ll now...
SEHK:2269
SEHK:2269Life Sciences

Is WuXi Biologics (SEHK:2269) Attractive After Its Five Year Share Price Reset?

If you are wondering whether WuXi Biologics (Cayman) is priced attractively right now, it helps to start with a clear view of what the market has been paying for the stock and why. The share price last closed at HK$33.04, with returns of a 2.6% decline over 7 days, 0.1% over 30 days, 1.5% year to date, 44.9% over 1 year, a 29.5% decline over 3 years, and a 68.9% decline over 5 years, a mix that can signal changing expectations around both growth potential and risk. Recent coverage has...
NYSE:KEY
NYSE:KEYBanks

Is It Time To Reassess KeyCorp (KEY) After Its Strong 1 Year Share Price Run?

If you are wondering whether KeyCorp's current share price offers value, it helps to step back and look at what the market has been pricing in recently. The stock last closed at US$22.11, with returns of 0.5% over 7 days, 10.3% over 30 days, 5.4% year to date, 54.2% over 1 year and 22.9% over 5 years. This gives you a sense of how sentiment has shifted over different time frames. Recent headlines around KeyCorp have focused on the broader banking sector's funding costs, regulatory scrutiny...